Previous Close | 306.00 |
Open | 303.50 |
Bid | 306.90 x N/A |
Ask | 310.10 x N/A |
Day's Range | 303.50 - 305.60 |
52 Week Range | 145.45 - 307.50 |
Volume | |
Avg. Volume | 7 |
Market Cap | 11.49B |
Beta (5Y Monthly) | 0.88 |
PE Ratio (TTM) | 84.65 |
EPS (TTM) | 3.61 |
Earnings Date | May 06, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 210.67 |
Shockwave Medical (SWAV) concluded the recent trading session at $329, signifying a +0.45% move from its prior day's close.
Johnson & Johnson CFO Joseph Wolk discusses the company's first-quarter earnings, forecast and product pipeline on Bloomberg Television. Johnson & Johnson's first-quarter drug sales narrowly outpaced Wall Street expectations as the company beat profit estimates.
Shockwave Medical (SWAV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.